Medical Oncology · Acibadem Atasehir Hospital, İstanbul Prof. Dr. Hüseyin Engin
✓ Medically verified profileProf. Dr. Hüseyin Engin
Prof. Dr. Hüseyin Engin is a medical oncologist in the Medical Oncology Department at Acibadem Atasehir Hospital in İstanbul, Turkey. He treats solid tumors including head and neck cancers, soft tissue and bone sarcomas, prostate, ovarian, pancreatic, gallbladder and bile duct, gastric, colorectal, lung and thoracic, and kidney cancers. He consults in Turkish and English.
Accepting international patientsAbout Prof. Dr. Hüseyin Engin
Prof. Dr. Hüseyin Engin is a medical oncologist in the Medical Oncology Department at Acibadem Atasehir Hospital in İstanbul. He has more than 32 years in medicine and has been working with Acıbadem Healthcare Services since 2022. His clinical work is centered on the systemic treatment of solid tumors, including head and neck cancers, soft tissue and bone sarcomas, and cancers of the prostate, ovary, pancreas, gallbladder and bile ducts, stomach, colon and rectum, lung and thorax, and kidney.
Dr. Engin graduated from Hacettepe University Faculty of Medicine in 1994. He completed his Internal Medicine training there in 1999 and his Medical Oncology training in 2003, serving as a subspecialty resident in the Department of Internal Medicine, Division of Medical Oncology from 1999 to 2003. During the same period he attended the Tumor Biology and Immunology MSc Degree Program at Hacettepe University Oncology Institute, Division of Basic Oncology, as a special student. After working as a specialist doctor at Burhan Nalbantoğlu State Hospital in Lefkoşa, KKTC, in 2003 and at Özel Zonguldak A Medical Center in 2004, he joined Zonguldak Bülent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, where he held appointments as assistant professor (2004–2006), associate professor (2006–2012) and professor (2012–2021). In 2021 he held a professorship at Şişli Hamidiye Etfal Training and Research Hospital. He is a member of ESMO (European Society for Medical Oncology), the Turkish Oncology Group Flims Alumni Club (FAC), the Turkish Internal Medicine Specialists Association and the Medical Oncology Association. He is a co-author of peer-reviewed publications on topics that include chemotherapy in metastatic pancreatic cancer, metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer, and metastatic renal cell carcinoma.
Clinical focus
Dr. Engin assesses and plans medical oncology care for a range of solid tumors. His areas of expertise include head and neck cancers, soft tissue and bone sarcomas, prostate cancer, ovarian cancer and kidney cancer. Within gastrointestinal oncology, he treats patients with pancreatic cancer, gallbladder and bile duct cancers, gastric cancer and colorectal cancer.
He also cares for patients with lung and other thoracic cancers. In each case, the treatment approach depends on the type and stage of the tumor, previous treatments and the patient’s overall condition, and is discussed individually with the patient after a review of the available findings.
How Dr. Engin works with international patients
Dr. Engin consults in Turkish and English, and interpreters can be arranged for other languages. The Acibadem international patient team coordinates the collection of prior reports and imaging, arranges appointments and organises the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the options. Video consultation is available for international patients who wish to discuss their case before or instead of traveling.
Meet Prof. Dr. Hüseyin Engin
Hüseyin Engin, Professor of Medical OncologyWhat Dr. Engin treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Education, career and memberships
Education & training
Education
- 2003Hacettepe University Faculty of Medicine Medical Oncology
- 1999Hacettepe University Faculty of Medicine Internal Medicine
- 1994Hacettepe University Faculty of Medicine
Career
Professional Experience
- 2022Acıbadem Healthcare Services
- 2021Şişli Hamidiye Etfal Training and Research Hospital / Prof. Dr.
- 2012–2021Zonguldak Bülent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology / Prof. Dr.
- 2006–2012Zonguldak Bülent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology / Assoc. Prof. Dr.
- 2004–2006Zonguldak Bülent Ecevit University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology / Asst. Prof. Dr.
- 2004Özel Zonguldak A Medical Center, Zonguldak / Specialist Doctor
- 2003Burhan Nalbantoğlu State Hospital, Lefkoşa, KKTC / Specialist Doctor
- 1999–2003Hacettepe University Faculty of Medicine / Department of Internal Medicine / Division of Medical Oncology / Subspecialty Resident
- 1999–2003Tumor Biology and Immunology MSc Degree Program, Hacettepe University Oncology Institute, Division of Basic Oncology / Special Student
- 1994–1999Hacettepe University Faculty of Medicine, Department of Internal Medicine / Research Assistant Dr.
Memberships
Professional Memberships
- Turkish Oncology Group Flims Alumni Club (FAC)
- ESMO (European Society for Medical Oncology)
- Turkish Internal Medicine Specialists Association
- Medical Oncology Association
Selected publications
Selected Publications
- Intraoperative Ultrasonography-Guided Surgery; An effective modality for breast conservation after neo-adjuvant ehemotherapy Breast Journal. 2020;26:1680-1687 Taşdöven İ, Çakmak GK, Emre AU, Engin H. Bahadır B, Bakkal BH, Güllüoğlu MB.
- Serum Sulphate Levels in Hemodialysis Patients Int J Nephrol. 2019 Dec 1;2019:1063514. doi: 10.1155/2019/1063514. eCollection 2019 Yildirim I, Hur E, Magden K, İlikhan S, Engin H, Can M, Yıldız G, Özer İ.
- Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospeetive analysis Urun Y. J BUON. 2018 Dec;23(7): 116-121. Ergun Y, Ozdemir NY, Guner EK, Esin E, Sendur MA, Koksoy EB, Demirci NS, Eren T, Dede I, Sezer A, Engin H, Oksuzoglu B, Yalcin B, Utkan G, Zengin N,
- The effects of zoledronic acid on ECG: a prospeetive study on patients with bone metastatic cancer Clin Cases Miner Bone Metab. 2017 Jan-Apr; 14(1):35-39. doi: 10.11138/ccmbm/2017.14.1.035. Epub 2017 May 30. Demirtas D, Bilir C, Demirtas AO, Engin H.
- Efficacv of metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer and poor performance status Curr Oncol. 2017 Jun;24(3):el99-e204. doi: 10.3747/co.24.3486. Epub 2017 Jun 27. Bilir C, Durak S, Kızılkaya B, Hacıbekiroglu I, Nayır E, Engin H.
- Prognostic value of total lesion glycolysis in stage IIIB/IV nonesmall cell lung cancer. Journal of Oncological Sciences 3 (2017) 107-11 Yusufoglu B, Bilir C, Engin H.
- A Study on the Relationship Between Leptin and Leptin Receptor Gene Variants and Colorectal Cancer. Muğla Sıtkı Koçman University Medical Journal. 2017;4(1): 10-14. Korkmaz N, Kimyon AS, Ermiş E, Edgünlü T, Arpacı E, Engin H. Karakaş Çelik S.
- Using Interferon Alpha Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Celi Carcinoma: A Turkish Oncology Group (TOG) Study Clin Genitourin Cancer. 2016 Aug; 14(4):e347-53. Artaç M, Çoşkun HŞ, Korkmaz L, Koçer M, Turhal IMS, Engin H. Dede İ, Paydaş S, Öksüzoğlu B, Bozcuk H, Demirkazık A.
- 10. Red Celi Distribution Width Has a Predictable Value for Differentiation of Provoked and Unprovoked Venous Thromboembolism Indian J Hematol Blood Transfus. 2016 Dec;32(4):481-487. Ertop S, Bilici M, Engin H, Buyukuysal C, Arslaner M, Toka B, Tekin
- Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients with non-metastatic triple-negative breast cancer Oncol Lett. 2015 Jun;9(6):2819-2824. Bilir C, Engin H, Can M, Likhan S, Demirtas D, Kuzu F, Bayraktaroglu T.
Frequently Asked Questions
Which cancers does Dr. Engin treat?
Where does Dr. Engin see patients?
Which languages does Dr. Engin speak?
What should I send for a review of my case?
Is a video consultation with Dr. Engin possible?
What is Dr. Engin's training and professional background?
What patients say about their Acibadem care
★★★★★From 2,400+ verified reviews across the Acibadem group“Choosing Acibadem for my infectious disease consultation was the best decision I made. Dr. Zengin explained every step clearly and never rushed me.”
“Years of worry ended once I came here for my lymphedema treatment. Dr. Zengin was honest about my options instead of pushing treatment.”
“My cancer treatment was handled with real skill and genuine care. Prof. Dr. Engin explained every step clearly and never rushed me. The facilities were spotless and modern.”

